Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04563910 Enrolling by invitation - Clinical trials for Patients Diagnosed With Bipolar Disorder ( Manic Episodes) and Delayed Diagnosis

Impact of Duration of Untreated Manic Episodes on Clinical Outcome

Start date: September 23, 2020
Phase:
Study type: Observational

The current study is cross sectional retrospective study, included 100 patients were diagnosed as mood disorder bipolar I (manic episodes) according to DSM5, patients recruited from inpatient psychiatric unit at department of Neurology and Psychiatry, Assiut University hospitals The current work is designed to study the effect of duration of untreated bipolar disorder on clinical outcome ( severity , residual symptoms ,duration of hospital admission) and to study factors affecting duration of untreatment in Upper Egypt.

NCT ID: NCT04561791 Enrolling by invitation - Barrett Esophagus Clinical Trials

Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

The investigators will conduct a large study in the primary care clinic to determine the feasibility of using tethered capsule endomicroscopy as a screening method for Barrett's esophagus (BE) in the primary care practice environment. The investigators are also determining the prevalence of Barrett's esophagus in a primary care practice cohort at MGH.

NCT ID: NCT04559334 Enrolling by invitation - Clinical trials for Central Line-associated Bloodstream Infection (CLABSI)

Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients

Start date: December 21, 2020
Phase: N/A
Study type: Interventional

In this research study we want to learn more about a study drug, tetrasodium sodium EDTA (Kitelockā„¢) for maintaining the patency (blood flow) through a central venous catheter. Catheter occlusions such as blood clots have been shown to increase the risk of central line-associated bloodstream infection (CLABSI). This treatment consists of instilling a daily a dose of a solution , similar to heparin or saline lock flushes, into the catheter when it is not in use. The aim is to prevent CLABSI without increasing complications such as catheter breakage.

NCT ID: NCT04548804 Enrolling by invitation - Cardiac Arrest Clinical Trials

Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI

BREACH-ECGI
Start date: June 10, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the electrophysiological properties of the heart conduction system in patients with (increased risk of) ventricular tachyarrhythmias (VTA) and sudden cardiac arrest, and in a control cohort. The electrophysiological properties will be measured with the relatively new technique ECG-Imaging (ECGI). Moreover, clinical data of subjects will be gathered. By combining the data from the data gathering and the results of ECGI, the investigators hope to increase mechanistic understanding of and risk stratification for VTAs. The investigators aim to be able to identify patients at risk of an arrhythmic event, and aim for better treatment strategies in the future.

NCT ID: NCT04545112 Enrolling by invitation - Clinical trials for Multi Vessel Coronary Artery Disease

Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)

XABG-FIH
Start date: October 22, 2020
Phase: N/A
Study type: Interventional

A FIH study to collect preliminary device safety, feasibility and performance data of the XABG in patients with symptomatic coronary artery disease (SCAD), with suitable multi vessel disease (MVD) and selected by the local Heart Team for elective coronary artery bypass grafts surgery of at least 3 bypass grafts (minimally 1 artery and 2 veins or 2 arteries and 1 vein).

NCT ID: NCT04540185 Enrolling by invitation - Covid19 Clinical Trials

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

OPV-NA831
Start date: November 1, 2020
Phase: Phase 3
Study type: Interventional

In this randomized double blind Phase 3 clinical trial we will study the efficacy and safety of oral polio vaccine with and without NA-831 versus placebo.

NCT ID: NCT04536064 Enrolling by invitation - Clinical trials for Description of an Effective Surgical Strategy to Treat Cancer Related Lymphedema, a High Incidence Pathology

COMBINATION OF LYMPHATICO-VENULAR ANASTOMOSIS AND LIPOSUCTION IN TREATING LYMPHEDEMA

Start date: February 22, 2021
Phase:
Study type: Observational

- cooperation of an International team with many years of experience in surgical management of lymphedema - description of an effective surgical strategy to treat cancer-related lymphedema, a high incidence pathology - the combination of LVA and liposuction guarantees long lasting results

NCT ID: NCT04534166 Enrolling by invitation - Clinical trials for Healthcare; Risk Prediction; Diabetic Patients With Osteoporosis

A Model for Risk Prediction of Fracture in Diabetic Patients With Osteoporosis

Start date: July 1, 2012
Phase:
Study type: Observational [Patient Registry]

The fracture risk of diabetic patients proves to be higher than those without diabetesdue to thehyperglycemia, usage of diabetes drugs, the changes in insulin levels and excretion, and this risk begins as early as adolescence.Many factors may be related to bone metabolism in patients with diabetes, including demographic data (e.g. age, height, weight, gender), medical history (e.g. smoking, drinking, menopause) and examination (e.g. bone mineral density, blood routine), urine routine).However, most of existing methods are qualitative assessments and do not take the interactions of the physiological factors of humans into consideration. In addition, the fracture risk of diabetic patients with osteoporosis has not been further studied before. In order to investigate the effect of patients' physiological factors on fracture risk, in the paper, we used a hybrid model combining XGBoost with deep neural network to predict the fracture risk of diabetic patients with osteoporosis.

NCT ID: NCT04529382 Enrolling by invitation - Clinical trials for Neurodevelopmental Abnormality

Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia

NOFNAIT
Start date: December 17, 2019
Phase:
Study type: Observational

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease caused by allo-immunisation during pregnancy. If left untreated, FNAIT can lead to severe fetal intracranial haemorrhage. This complication can be prevented by weekly administration of intravenous immunoglobulin (IVIg) to the mother during pregnancy. Knowledge on long-term development of FNAIT survivors with or without IVIg treatment is very limited but an important subject in the counselling of parents of newly diagnosed cases. To evaluate the long-term neurodevelopmental outcome in two groups of children with FNAIT will be asked to participate in our study in an outpatient clinic setting.

NCT ID: NCT04527822 Enrolling by invitation - Clinical trials for Coronary Artery Bypass Graft Surgery

Discharge Planning Program for Post CABG Patients

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The current study is utilizing a nurse led discharge program based on the Re-Engineered Discharge program (Project-RED) ( Agency of Healthcare Research and Quality [AHRQ], 2013) which is a package of services designed to minimize discharge failures and minimize re-admissions, reduce mortality, morbidity, complication and improve patients outcomes. Project-RED aims to reduce hospital re-admissions through a series of structured steps led by a nurse called discharge advocate. The intervention will be used to discharge patients post Coronary artery bypass graft surgery.